• Теги
    • избранные теги
    • Компании2845
      • Показать ещё
      Разное734
      • Показать ещё
      Страны / Регионы389
      • Показать ещё
      Международные организации42
      • Показать ещё
      Люди109
      • Показать ещё
      Формат39
      Показатели95
      • Показать ещё
      Издания18
      • Показать ещё
Gilead Sciences
24 апреля, 22:17

Celgene (CELG) to Post Q1 Earnings: What's in the Cards?

Celgene Corporation (CELG) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell.

24 апреля, 17:06

Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

24 апреля, 16:49

What's in Store for Agenus (AGEN) this Earnings Season?

Agenus Inc. (AGEN) is expected to report first-quarter 2017 results later this month or early next month.

Выбор редакции
24 апреля, 00:00

How Trump Could Make Your Drugs Cheaper...If He Dares

Daniel Malloy, OzyFor the more than 3 million Americans infected with potentially deadly hepatitis C, a relatively new cocktail of drugs is considered a miracle cure. The problem: Gilead Sciences’ list price is $84,000 for a 12-week treatment. From Martin Shkreli’s Turing Pharmaceuticals jacking up the AIDS drug Daraprim from $13.50 per pill to $750 in a single day to Mylan’s allergy-fighting EpiPens rising from $100 to $600 in just a few years, Americans are getting sick of astonishing drug prices. It’s why Donald Trump and Bernie Sanders both used their presidential campaigns to roast...

21 апреля, 18:21

What's in Store for GlaxoSmithKline (GSK) in Q1 Earnings?

GlaxoSmithKline plc (GSK) is scheduled to report first-quarter 2017 results on Apr 26 before market opens. Last quarter, the company delivered a positive earnings surprise of 14.04%.

21 апреля, 18:18

Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?

We expect biotech major Amgen Inc. (AMGN) to beat expectations when it reports first-quarter 2017 results on Apr 26 after the market closes.

21 апреля, 16:19

Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?

Alexion Pharmaceuticals, Inc. (ALXN) is scheduled to report first quarter 2017 results on Apr 27, before the opening bell.

20 апреля, 17:19

Novartis (NVS) Q1 Earnings: Will the Stock Disappoint?

Swiss pharmaceutical company Novartis AG (NVS) is scheduled to report first-quarter 2017 results on Apr 25.

18 апреля, 15:35

Did Pharma & Biotech M&As Pick Pace in Q1?

Post-election, hopes surged that there would be an increase in M&A activity in the pharma and biotech sector in 2017.

12 апреля, 14:36

Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback

Key highlights this week included pipeline updates from companies like Geron (GERN) and OncoMed.

11 апреля, 00:27

Gilead (GILD) HCV Drugs Gets FDA Nod for Label Expansion

Gilead Sciences, Inc. (GILD) announced that the FDA approved additional indications for Harvoni tablets and Sovaldi tablets.

06 апреля, 16:56

Акция, обогатившая однажды, сделает это снова

Что делать, когда фондовый рынок упорно растет несколько лет кряду, и никакая холера его не берет? В США в президенты избрали неожиданного персонажа, ФРС перешла к монетарному ужесточению, а индексы все ползут и ползут вверх, начиная нервировать держателей длинных позиций. Как обезопасить себя на тот случай, если "начало конца" придет нежданно? Лично я в такие времена занимаюсь тем, что ищу вложения, заметно падающие на растущем рынке при хороших финансовых показателях и осязаемых фундаментальных перспективах. К числу таких относится биофармацевтическая компания Gilead Sciences, акции которой находятся в фазе просадки с середины 2015 года. Скажу по секрету, что мне удалось неплохо заработать на акциях Gilead энное количество лет назад.

06 апреля, 16:30

KMG Chemicals, Gilead Sciences, STMicroelectronics NV, Lockheed Martin and AeroVironment highlighted as Zacks Bull and Bear of the Day

KMG Chemicals, Gilead Sciences, STMicroelectronics NV, Lockheed Martin and AeroVironment highlighted as Zacks Bull and Bear of the Day

06 апреля, 14:15

Bear of the Day: Gilead Sciences (GILD)

Bear of the Day: Gilead Sciences (GILD)

05 апреля, 15:59

Biotech Stock Roundup: Acorda Down on Court Ruling, Patent Challenge for CELG Drug

Court rulings and patent challenges made headlines in the biotech sector with companies like Acorda (ACOR) and Celgene (CELG) providing updates.

05 апреля, 14:40

Gilead (GILD) Up 4.3% Since Earnings Report: Can It Continue?

Gilead (GILD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

04 апреля, 23:55

Galapagos Initiates 3 Phase II Studies for Filgotinib

Galapagos NV (GLPG) announced that it has initiated three new phase II Proof-of-Concept studies evaluating its pipeline candidate filgotinib in Sjogren's syndrome, ankylosing spondylitis (AS), and psoriatic arthritis.

Выбор редакции
31 марта, 17:37

New Strong Sell Stocks for March 31st

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

29 марта, 15:15

Biotech Stock Roundup: Regeneron, Tesaro Drugs Approved, Vertex Scores Big in Study

Key updates this week include the FDA approval of Tesaro's (TSRO) PARP inhibitor and Regeneron's eczema drug.